share_log

B of A Securities Initiates Coverage On Amphastar Pharma With Neutral Rating, Announces Price Target of $63

B of A Securities Initiates Coverage On Amphastar Pharma With Neutral Rating, Announces Price Target of $63

Bof A Securities以中性評級啓動對Amphastar Pharma的報道,宣佈目標股價爲63美元
Benzinga ·  2023/11/17 08:12

B of A Securities analyst Jason Gerberry initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Neutral rating and announces Price Target of $63.

Bof A Securities分析師傑森·格伯裏以中性評級開始對Amphastar Pharma(納斯達克股票代碼:AMPH)進行報道,並宣佈目標股價爲63美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論